Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

idaman pharma sdn. bhd. - streptokinase -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

beacon pharmaceuticals ltd - streptokinase - powder for solution for infusion - 250000unit

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

beacon pharmaceuticals ltd - streptokinase - powder for solution for infusion - 750000unit

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

beacon pharmaceuticals ltd - streptokinase - powder for solution for infusion - 1.5mega unit

New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - streptokinase 1.5e+006 [iu] - powder for injection - 1.5e+006 iu - active: streptokinase 1.5e+006 [iu] excipient: albumin monosodium glutamate polygeline

New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - streptokinase 250000 [iu] - powder for injection - 250000 iu - active: streptokinase 250000 [iu] excipient: albumin monosodium glutamate polygeline

New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - streptokinase 750000 [iu] - powder for injection - 750000 iu - active: streptokinase 750000 [iu] excipient: albumin monosodium glutamate polygeline

Israel - English - Ministry of Health

genmedix , israel - streptokinase - powder for solution for infusion - streptokinase 750000 iu/vial - streptokinase - streptokinase - acute myocardial infarction, deep vein thrombosis, pulmonary embolism, acute or subacute thrombosis of peripheral arteries and chronic occlusive arterial diseases, occlusion of central retinal artery or vein.

Israel - English - Ministry of Health

genmedix , israel - streptokinase - powder for solution for injection - streptokinase 1500000 iu - streptokinase - streptokinase - systemic administration: in deep vein thromboses, lung embolism, acute myocardial infarction for re-opening of coronary vessels. in acute and subacute thromboses of peripheral arteries and chronic occlusive arterial diseases, occlusion of central retinal artery or vein. local administration: in acute myocardial infarction for re-opening of coronary vessels, in acute, subacute and chronic thromboses as well as embolisms of peripheral arteries.

Malta - English - Medicines Authority

biomed-lublin wytwórnia surowic i szczepionek spolka akcyjna 10 uniwersytecka str. ,20-029, lublin, poland - streptokinase, streptodornase - suppository - streptokinase 15000 iu streptodornase 1250 iu - other hematological agents